MT695508
Miniopterus fuliginosus isolate N21005 D-loop, partial sequence; mitochondrial.
294
DNA
Miniopterus fuliginosus
N21005
yx57h04.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:265879 3' similar to SP:S33295 S33295 TRANSLOCON-ASSOCIATED PROTEIN -, mRNA sequence.
572
mRNA
Homo sapiens
LF680226
JP 2016521556-A/21005: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
MB810263
JP 2019502674-A/21005: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
38
PRT
synthetic construct
LV566827
JP 2017029159-A/21005: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DJ150385
JP 2007228956-A/21003: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
MD267138
JP 2020517247-A/21005: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
MC162849
JP 2019500349-A/21005: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
MD753247
JP 2019507579-A/21005: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
PA525489
JP 2022502046-A/8271: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DL902749
JP 2014205669-A/21005: Method of constructing and screening libraries of peptide structures.
30
PRT
synthetic construct
HW856229
JP 2015051004-A/20957: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
FU795486
JP 2009528046-A/21003: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
DM722150
JP 2016500250-A/21005: ENGINEERED SECRETED PROTEINS AND METHODS.
133
PRT
Saccharomyces cerevisiae
DD547608
JP 2004508801-A/21005: NEISSERIAL ANTIGENIC PEPTIDES.
64
PRT
Neisseria
MC773115
JP 2018525446-A/21005: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
21
PRT
synthetic construct
OG657391
JP 2021500321-A/21005: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
HV877546
JP 2010507387-A/20957: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
PA336653
JP 2021522188-A/21005: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
PA391728
JP 2021533803-A/20811: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
DM795463
JP 2014068652-A/21005: NEISSERIAL ANTIGENIC PEPTIDES.
64
PRT
Neisseria
LF828161
JP 2016528161-A/20994: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
LX118621
JP 2017506877-A/21003: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
HZ525786
JP 2016501039-A/21005: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
HW186033
JP 2013102767-A/20957: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
DL611607
JP 2011092200-A/21005: NEISSERIAL ANTIGENIC PEPTIDES.
64
PRT
Neisseria
PD708919
JP 2021530475-A/21001: De novo Design of Protein Switches.
60
PRT
synthetic construct
DD801275
JP 2008525033-A/21005: Group B Streptococcus.
1182
PRT
Streptococcus agalactiae
DL030019
JP 2005512499-A/21005: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
894
DNA
synthetic construct
DJ524805
JP 2010517930-A/21005: Method of constructing and screening libraries of peptide structures.
30
PRT
synthetic construct